fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

A visit from a social robot improves hospitalized children’s outlook

Written by | 20 Oct 2021

A new study from UCLA finds a visit from human-controlled robot encourages a positive outlook and improves medical interactions for hospitalized children. Robin is a social companion robot… read more.

FDA approves Qulipta for prevention of migraine – AbbVie

Written by | 19 Oct 2021

The FDA has approved Qulipta (atogepant tablets), from AbbVie, for the preventive treatment of episodic migraine in adults. The approval of Qulipta was based on findings from the… read more.

COVID-19 vaccine elicits antibodies in 90% taking immunosuppressants

Written by | 19 Oct 2021

COVID-19 vaccination elicited antibody responses in nearly nine out of 10 people with weakened immune systems, although their responses were only about one-third as strong as those mounted… read more.

ViiV Healthcare submits extended approval request for tablet formulation of Triumeq for HIV to FDA

Written by | 18 Oct 2021

ViiV Healthcare has announced it has made a regulatory submission to the FDA for approval of a new dispersible tablet formulation of the fixed dose combination of abacavir,… read more.

More effective fitness trackers, more physical activity

Written by | 18 Oct 2021

Researchers apply engineering tools to personalize fitness tracker messages. As the popularity of fitness trackers has increased, so have the opportunities to use such devices to not only… read more.

FDA accepts REGEN-COV for priority review for treatment and prophylaxis of COVID-19 – Regeneron Pharma

Written by | 17 Oct 2021

Regeneron Pharmaceuticals, Inc. has announced that the FDA has accepted for priority review a Biologics License Application (BLA) for REGEN-COV (casirivimab and imdevimab) to treat COVID-19 in non-hospitalized… read more.

Pain monitoring helps assess the effectiveness of opioid-sparing approaches during surgery

Written by | 17 Oct 2021

A new study has shown that effective opioid-sparing anaesthesia with dexmedetomidine can be guided with NOL pain monitoring technology (Medasense, Israel). The study showed that the NOL monitor… read more.

FDA approves Tavneos for vasculitis – ChemoCentryx

Written by | 16 Oct 2021

ChemoCentryx announced that the FDA has approved Tavneos (avacopan), an orally administered selective complement 5a receptor inhibitor, as an adjunctive treatment of adult patients with severe active anti-neutrophil… read more.

Parental smoking may increase children’s risk of developing rheumatoid arthritis

Written by | 16 Oct 2021

New research published in Arthritis & Rheumatology links parental smoking with an elevated risk of rheumatoid arthritis in children when they reach adulthood. Among 90,923 participants in the Nurses’ Health… read more.

Spinal and general anesthesia associated with similar outcomes in hip-fracture surgery

Written by | 15 Oct 2021

For survival and functional recovery, spinal anesthesia for hip-fracture surgery is not superior to general anesthesia, researchers reported on Oct. 9 in the NEJM/New England Journal of Medicine…. read more.

New research could help clear backlog of surgery

Written by | 15 Oct 2021

New research published in Anaesthesia (a journal of the Association of Anaesthetists) by researchers from the University of Bristol can help to improve the efficiency of surgery and help tackle… read more.

Hugo Robotic-Assisted Surgery System receives European CE Mark approval – Medtronic

Written by | 14 Oct 2021

Medtronic plc announced it has received CE (Conformité Européenne) Mark for the Hugo robotic-assisted surgery (RAS) system, authorizing the sale of the system in Europe. CE Mark approval… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.